{"id":"tp-59468","type":"article-newspaper","title":"SELLAS Life Sciences Shares Surge More Than 281% After Trial Results","author":"Enna Lee","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/investing/59468","datePublished":"2026-11-17T14:15:49.000Z","dateModified":"2026-11-17T14:15:49.000Z","language":"en","abstract":"The Phase 3 REGAL trial showed improved overall survival among patients with acute myeloid leukemia.","section":"Investing","references":[]}